Method for crosslinking of haemoglobin
US5563047A · kind A · utility
19Cited by
10References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 10, 1995 |
| Grant date | Oct 8, 1996 |
| Priority date | — |
| Expiry date | May 10, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Haemoglobin is crosslinked by means of transglutaminase, whereafter the transglutaminase is inactivated. The crosslinked haemoglobin can be used as a molecular agent for oxygen transportation, as an oxygen scavenger, and as a constituent of a food composition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.